Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study

AIM: To evaluate the safety of 1.25mg and 2mg intravitreal ziv-aflibercept (IVZ) in Ghanaian eyes with choroido-retinal vascular diseases. DESIGN: Prospective, randomised, double blind, interventional study. METHODS: Twenty patients with centre involving macular oedema in diabetic retinopathy, retin...

Descripción completa

Detalles Bibliográficos
Autores principales: Braimah, Imoro Zeba, Kenu, Ernest, Amissah-Arthur, Kwesi N., Akafo, Stephen, Kwarteng, Kwaku Oppong, Amoaku, Winfried M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812750/
https://www.ncbi.nlm.nih.gov/pubmed/31647843
http://dx.doi.org/10.1371/journal.pone.0223944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812750/
https://www.ncbi.nlm.nih.gov/pubmed/31647843
http://dx.doi.org/10.1371/journal.pone.0223944

Ejemplares similares